US › Healthcare

Airsculpt Technologies Inc (AIRS)

US · Healthcare · Medical Care Facilities

$4.96+1.64%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$39.4M
Revenue YoY
0.0%
Net profit
$-2.4M
Profit YoY
+15.8%
EPS
$-0.03
EPS estimate
$-0.02
Net margin
-6.1%

EPS came in at -0.03 against a street estimate of -0.02 — a miss of 50.0%.

Key statistics

Market cap
$344.3M
Forward P/E
0.0
P/B
3.39
Book value
$1.42
EPS (TTM)
$-0.17
52-week high
$12.00
52-week low
$1.51
50-day MA
$4.81
200-day MA
$4.03
Beta
2.37

Analyst view

Analysts rate Airsculpt Technologies Inc a hold (0 buy, 4 hold, 0 sell out of 4) with an average price target of $6.25.

Shareholding

Insiders
43.06%
Institutions
66.07%

Largest institutional holders

FundStake
Vesey Street Capital Partners, L.L.C.42.99%
Balyasny Asset Management LLC3.30%
FourWorld Capital Management LLC1.40%
BlackRock Inc1.14%
Wexford Capital LP0.95%
UBS Group AG0.88%
Susquehanna International Group, LLP0.67%
Geode Capital Management, LLC0.52%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Airsculpt Technologies Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.